99m Tc-Sestamibi SPECT/CT and histopathological features of oncocytic renal neoplasia.
Antonios TzortzakakisThomas PapathomasOve GustafssonStefan GabrielsonKiril TrpkovLinnea Ekström-EhnAlexandros ArvanitisMaria HolstenssonMattias KarlssonGeorgia KokarakiRimma AxelssonPublished in: Scandinavian journal of urology (2022)
The imaging limitations for accurate differentiation of Sestamibi-positive renal tumours mirror the recognised diagnostic complexities of the histopathologic evaluation of oncocytic neoplasia. Patients with Sestamibi-positive renal tumours could be better suited for biopsy and follow-up, according to the current active surveillance protocols.